Lessons investors can take from the U.S. when looking at life sciences
Munich, 08/17/2022
The pandemic accelerated life sciences as a strategic sector in many countries across the globe. As such, the sector will continue to act as a magnet for private and public funding. Nevertheless, the relatively small size of life sciences markets coupled with high investor concentration makes it challenging for new entrants to gain access and build scale into the sector.
How can core investors break the barriers to entry? What is the life sciences ecosystem and why does it have an undeniable competitive advantage? And why do life sciences locations tend to expand to urban centers in Europe but to suburbs in the U.S.?
Find out the answers to the most crucial questions about investing in life sciences in our latest report and understand why we think life sciences returns should remain resilient despite current macroeconomic uncertainty.
Read the full report Investing in global life sciences clusters: lessons from the U.S. HERE.
Press Contact:
Paula Eirich
Head of External Communications
Allianz Real Estate GmbH and Allianz Real Estate of America, their subsidiaries and affiliates are known jointly as “Allianz Real Estate”. Allianz Real Estate is a PIMCO company. When introducing a property investment opportunity to Allianz Real Estate you acknowledge that we are under no obligation to accept your introduction or enter into any agreement with you. Fees, commission or other payments in respect of introductions shall only be payable where there is a signed written agreement to that effect entered into between Allianz Real Estate and the introducer. By submitting an introduction to Allianz Real Estate you shall be deemed to have accepted the aforementioned terms.
PIMCO is a trademark of Allianz Asset Management of America L.P. in the United States and throughout the world. ©2022, PIMCO.